Am J Transplant, Volume 19, Suppl 3 Archives - Page 29 of 214 - ATC Abstracts

2019 American Transplant Congress
Lung Transplant Outcomes after CABG
S. Huddleston¹, R. Aggarwal¹, S. Jackson², N. Lemke¹
¹Surgery, University of Minnesota, Minneapolis, MN, ²Surgery, Fairview Health Services, Minneapolis, MN
*Purpose: Prior coronary artery bypass grafting (CABG) has been a contraindication to lung transplantation (LTx) due to increased mortality associated with bilateral lung transplant. We…
2019 American Transplant Congress
C4d Positivity in Renal Biopsies Following A₂ to B Kidney Transplantation: Not All A B O Incompatibilities Are Equal
S. Radomski¹, G. Vranic², B. Thomas², P. Abrams², M. Cooper², A. Gilbert²
¹Georgetown University School of Medicine, Washington, DC, ²Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: With the new allocation rules implemented in 2014, the number of transplants from A2 and A2B donors to B or O recipients (minor ABO…
2019 American Transplant Congress
Increase in Deceased Donor Acceptance Rate After Implementing Uniform Acceptance Criteria
C. Klein, T. Ommert, J. Hundley, J. Lizcano, A. Ray, R. Cross, K. Payne
Piedmont Transplant Institute, Atlanta, GA
*Purpose: Over 100,000 candidates are listed for kidney transplant in the United States, yet less than 20,000 patients are transplanted annually. In 2013, over 2,500…
2019 American Transplant Congress
Predictors of Multidrug-Resistant Organisms among Solid Organ Transplant Donors
J. A. Anesi¹, E. A. Blumberg¹, J. H. Han¹, D. H. Lee², H. Clauss³, A. Climaco⁴, R. Hasz⁵, E. Molnar³, D. Alimenti¹, S. West⁵, W. Bilker¹, P. Tolomeo¹, E. Lautenbach¹
¹University of Pennsylvania, Philadelphia, PA, ²Drexel University College of Medicine, Philadelphia, PA, ³Temple University, Philadelphia, PA, ⁴Albert Einstein Medical Center, Philadelphia, PA, ⁵Gift of Life Donor Program, Philadelphia, PA
*Purpose: Transplant guidelines recommend exercising caution when considering donor organs that may be infected or colonized with multidrug-resistant organisms (MDROs). Approaches to identifying such potentially…
2019 American Transplant Congress
Microscopic Hepatic Steatosis Prior to Liver Transplantation Influences Clinical Outcomes
K. Nakamura, H. Hirao, T. Ito, S. Kageyama, K. Kadono, K. J. Dery, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski
Surgery, Liver Transplant, UCLA, Los Angeles, CA
*Purpose: Although liver transplantation (LT) has become a standard care for end-stage liver diseases, early allograft dysfunction (EAD) and rejection crises curtail the outcomes. Considering…
2019 American Transplant Congress
Anti- CD154 / CD40 Costimulation Blockade is Superior to Tacrolimus in Prolonging Survival in Pig-to-Nonhuman Primate Renal Xenotransplantation
B. P. Lovasik¹, A. J. Matar¹, C. Breeden¹, J. Jenkins², J. Tector³, S. C. Kim¹, A. B. Adams¹
¹Emory Transplant Center, Emory University, Atlanta, GA, ²Yerkes National Primate Center, Emory University, Atlanta, GA, ³University of Alabama at Birmingham, Birmingham, AL
*Purpose: Costimulation blockade strategies targeting the CD40/CD154 pathway are highly effective in preventing xenograft rejection in pig-to-nonhuman primate (NHP) transplantation models. The aim of this…
2019 American Transplant Congress
Association of Pretransplant and Posttransplant 5-Tier Ratings with Candidate Mortality after Listing
A. Wey, S. Gustafson, N. Salkowski, B. Kasiske, M. Skeans, C. Schaffhausen, A. Israni, J. Snyder
SRTR, Minneapolis, MN
*Purpose: The OPTN Final Rule mandates the Scientific Registry of Transplant Recipients (SRTR) to publish understandable reports of transplant rate, waitlist mortality, and posttransplant outcomes.…
2019 American Transplant Congress
The National Landscape of Heart Transplant Candidates with HIV
A. A. Shaffer¹, A. G. Thomas², D. L. Segev¹
¹Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC
*Purpose: Heart disease is a leading cause of death for HIV+ individuals, and the number of HIV+ heart transplant (HT) recipients is growing. Although understanding…
2019 American Transplant Congress
Using Ensembles of Machine Learning Classifiers to Maximize the Accuracy and Stability of Molecular Biopsy Interpretation
J. Reeve¹, K. S. Madill-Thomsen², P. F. Halloran and the INTERCOMEX Study Group³
¹University of Alberta, Edmonton, AB, Canada, ²Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton AB, AB, Canada, ³University of Alberta, Edmonton AB, AB, Canada
*Purpose: The Molecular Microscope diagnostic system (MMDx), based on microarray gene expression, uses ensembles of machine learning classifiers rather than single genes, gene sets, or…
2019 American Transplant Congress
Using a Commercially Available Assay That Measures Cytomegalovirus-Specific CD4+ and CD8+ T-cell Immunity to Predict Clinically Significant Cytomegalovirus Events in Solid Organ Transplant Recipients
R. Rogers¹, K. Saharia², A. Chandorkar², Z. Weiss³, D. Farmakiotis¹
¹Infectious Diseases, Brown University, Providence, RI, ²Infectious Diseases, University of Maryland, Baltimore, MD, ³Internal Medicine, Brown University, Providence, RI
*Purpose: To assess the diagnostic performance and clinical utility of the Viracor CMV T-cell Immunity Panel (CMV-TCIP), which measures both CMV-specific Cd4+ and Cd8+ T-cell…